Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
October 04, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Break the Silence; New Intensive Online Program to Help PTSD, Trauma and Anxiety
September 29, 2022 15:00 ET
|
Purple Heart Behavioral Health LLC
SCOTTSDALE, Ariz., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Purple Heart Behavioral Health LLC, a premier telepsychology trauma service, announced today an innovative program for PTSD, Anxiety and Stress...
Gather Behavioral Health Launches to Meet Growing Need for In-Person and Virtual Outpatient Therapy and Nutrition Services
September 22, 2022 08:00 ET
|
Accanto Health
ST. PAUL, Minn. and EAU CLAIRE, Wis., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Gather Behavioral Health, an outpatient practice offering in-person and virtual treatment for a variety of mental health...
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
September 21, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
September 13, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Heroic Hearts Project and Maya Partner to Establish Advanced Data Capture Protocols for Veterans Seeking Psychedelic Treatments
September 01, 2022 10:15 ET
|
Heroic Hearts Project
NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Today, Heroic Hearts Project and Maya PBC announced their partnership in support of aggregating clinical evidence for health outcomes achieved through...
Bionomics to Participate in Upcoming September Investor Conferences
August 31, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics reports Full Year Financial Results
August 25, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq:BNOX), today announced its financial results for the 12 months ended 30 June 2022. Bionomics is a clinical...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
August 18, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
August 10, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products,...